Peter Boström

Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor (2020)

European Urology Oncology

Gregory J Nason, Michael A S Jewett, Peter J Boström, Hanan Goldberg, Aaron R Hansen, Philippe L Bedard, Jeremy Sturgeon, Padraig Warde, Peter Chung, Lynn Anson-Cartwright, Joan Sweet, Eshetu G Atenafu, Martin O'Malley, Robert J Hamilton

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (2020)

New England Journal of Medicine

Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B; for the HERO Study Investigators

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study (2020)

World Journal of Urology

Falagario U, Jambor I, Taimen P, Syvänen KT, Kähkönen E, Merisaari H, Montoya Perez I, Knaapila J, Steiner A, Verho J, Tewari A, Aronen HJ, Carrieri G, Boström PJ, Ettala O

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer? (2020)

Acta Oncologica

V. Madekivi, P. Boström, A. Karlsson, R. Aaltonen, E. Salminen

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques (2020)

Journal of Magnetic Resonance Imaging

Ileana Montoya Perez, Ivan Jambor, Tapio Pahikkala, Antti Airola, Harri Merisaari, Jani Saunavaara, Saeid Alinezhad, Riina-Minna Väänänen, Terhi Tallgrén, Janne Verho, Aida Kiviniemi, Otto Ettala, Juha Knaapila, Kari T. Syvänen, Markku Kallajoki, Paula Vainio, Hannu J. Aronen, Kim Pettersson, Peter J. Boström, Pekka Taimen

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4 (2019)

European Urology

Kimmo Kettunen, Peter J. Boström, Pekka Taimen

(Muu (O2))

Adverse Events During Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer (2019)

Bladder Cancer

Salminen Antti P, Montoya Perez Ileana, Klén Riku, Ettala Otto O, Syvänen Kari T, Elo Laura L, Boström Peter J

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Reply to Joshua S. Jue and Mahmoud Alameddine's Letter to the Editor re: Juha Knaapila, Ivan Jambor, Ileana Montoya Perez, et al. Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study (2019)

European Urology Oncology

Knaapila J, Jambor I, Falagario U, Ettala O, Syvänen KT, Boström PJ

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology (2019)

Scandinavian Journal of Urology

Klen Riku, Salminen Antti P, Mahmoudian Mehrad, Syvänen KT, Elo Laura L, Boström Peter J

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization (2019)

PLoS ONE

Jussi Toivonen, Ileana Montoya Perez, Parisa Movahedi, Harri Merisaari, Marko Pesola, Pekka Taimen, Peter J. Boström, Jonne Pohjankukka, Aida Kiviniemi, Tapio Pahikkala, Hannu J. Aronen, Ivan Jambor

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor (2020)

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (2020)

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study (2020)

Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer? (2020)

Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques (2020)

Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4 (2019)

Adverse Events During Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer (2019)

Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology (2019)

Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization (2019)